Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Background: HIV-infected persons with detectable cryptococcal antigen (CrAg) in blood have increased morbidity and mortality compared with HIV-infected persons who are CrAg-negative. This study examined neurocognitive function among persons with asymptomatic cryptococcal antigenemia.Methods: Partici...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Neurology Vol. 17; pp. 1 - 10
Autores principales: Montgomery, Martha P., Nakasujja, Noeline, Morawski, Bozena M., Rajasingham, Radha, Rhein, Joshua, Nalintya, Elizabeth, Williams, Darlisha A., Hullsiek, Kathy Huppler, Kiragga, Agnes, Rolfes, Melissa A., Carlson, Renee Donahue, Bahr, Nathan C., Birkenkamp, Kate E., Manabe, Yukari C., Bohjanen, Paul R., Kaplan, Jonathan E., Kambugu, Andrew, Meya, David B., Boulware, David R., Huppler Hullsiek, Kathy
Formato: research tables/charts Journal Article
Publicado: BioMed Central 6/12/2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=123618691&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 123618691
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712377
        1CI7
      jtl: BMC Neurology
      issn: 14712377
      maglogo: N
    pubinfo:
      dt: 6/12/2017
      vid: 17
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        123618691
        123618691
        NLM28606065
        123618691
        10.1186/s12883-017-0878-2
        NLM28606065
        123618691
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.
      aug:
        au:
          Montgomery, Martha P.
          Nakasujja, Noeline
          Morawski, Bozena M.
          Rajasingham, Radha
          Rhein, Joshua
          Nalintya, Elizabeth
          Williams, Darlisha A.
          Hullsiek, Kathy Huppler
          Kiragga, Agnes
          Rolfes, Melissa A.
          Carlson, Renee Donahue
          Bahr, Nathan C.
          Birkenkamp, Kate E.
          Manabe, Yukari C.
          Bohjanen, Paul R.
          Kaplan, Jonathan E.
          Kambugu, Andrew
          Meya, David B.
          Boulware, David R.
          Huppler Hullsiek, Kathy
        affil: Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota, 3-222 MTRF, 2001 6th St SE, Minneapolis, MN 55455, USA
      sug:
        subj:
          Cryptococcus
          HIV Infections Complications
          Meningitis, Cryptococcal Diagnosis
          Antigens, Fungal
          Female
          Prospective Studies
          Adult
          Male
          Human
          Funding Source
          Adult: 19-44 years
          Female
          Male
      ab: Background: HIV-infected persons with detectable cryptococcal antigen (CrAg) in blood have increased morbidity and mortality compared with HIV-infected persons who are CrAg-negative. This study examined neurocognitive function among persons with asymptomatic cryptococcal antigenemia.Methods: Participants from three prospective HIV cohorts underwent neurocognitive testing at the time of antiretroviral therapy (ART) initiation. Cohorts included persons with cryptococcal meningitis (N = 90), asymptomatic CrAg + (N = 87), and HIV-infected persons without central nervous system infection (N = 125). Z-scores for each neurocognitive test were calculated relative to an HIV-negative Ugandan population with a composite quantitative neurocognitive performance Z-score (QNPZ-8) created from eight tested domains. Neurocognitive function was measured pre-ART for all three cohorts and additionally after 4 weeks of ART (and 6 weeks of pre-emptive fluconazole) treatment among asymptomatic CrAg + participants.Results: Cryptococcal meningitis and asymptomatic CrAg + participants had lower median CD4 counts (17 and 26 cells/μL, respectively) than the HIV-infected control cohort (233 cells/μL) as well as lower Karnofsky performance status (60 and 70 vs. 90, respectively). The composite QNPZ-8 for asymptomatic CrAg + (-1.80 Z-score) fell between the cryptococcal meningitis cohort (-2.22 Z-score, P = 0.02) and HIV-infected controls (-1.36, P = 0.003). After four weeks of ART and six weeks of fluconazole, the asymptomatic CrAg + cohort neurocognitive performance improved (-1.0 Z-score, P < 0.001).Conclusion: Significant deficits in neurocognitive function were identified in asymptomatic CrAg + persons with advanced HIV/AIDS even without signs or sequelae of meningitis. Neurocognitive function in this group improves over time after initiation of pre-emptive fluconazole treatment and ART, but short term adherence support may be necessary.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N